Novavax’s shot is made with lab-grown copies of the spike protein that coats the coronavirus, which then trigger an immune response. ADVERTISEMENT In June, Maryland-based Novavax announced the vaccine had proven about 90% effective against symptomatic COVID-19 in a study of nearly 30,000 people in the United States and Mexico.

